Activity-Modulating Monoclonal Antibodies to the Human Serine Protease HtrA3 Provide Novel Insights into Regulating HtrA Proteolytic Activities

• Harmeet Singh ,

  * E-mail: guiying.nie@mimr-phi.org (GN); harmeet.singh@mimr-phi.org (HS)

  Affiliations MIMR-PHI Institute of Medical Research, Clayton, Victoria, Australia, Monash University, Clayton, Victoria, Australia

  ⨯
• Tracy L. Nero,

  Affiliation ACRF Rational Drug Discovery Centre, St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia

  ⨯
• Yao Wang,

  Affiliations MIMR-PHI Institute of Medical Research, Clayton, Victoria, Australia, Monash University, Clayton, Victoria, Australia

  ⨯
• Michael W. Parker,

  Affiliations ACRF Rational Drug Discovery Centre, St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia, Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, the University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Guiying Nie

  * E-mail: guiying.nie@mimr-phi.org (GN); harmeet.singh@mimr-phi.org (HS)

  Affiliations MIMR-PHI Institute of Medical Research, Clayton, Victoria, Australia, Monash University, Clayton, Victoria, Australia

  ⨯